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Objective: To compare risk factors for severe disease
as measured by admission to hospital and intensive
care unit (ICU) and other clinical outcomes in children
with pandemic H1N1 (pH1N1) versus those with
seasonal inﬂuenza.
Design: Retrospective analysis of children admitted to
hospital with pH1N1 versus seasonal inﬂuenza A.
Setting: Canadian tertiary referral children’s hospital.
Participants: All laboratory-identiﬁed cases of pH1N1
in children younger than 18 years admitted to hospital
in 2009 (n¼176) and all seasonal inﬂuenza A cases
admitted to hospital from inﬂuenza seasons
2004e2005 to 2008e2009 (n¼200). Children with
onset of symptoms more than 3 days after admission
were excluded.
Primary and secondary outcome
measures: Primary outcomes include admission to
hospital and ICU and need for mechanical ventilation.
Secondary outcomes include length of stay in hospital
and duration of supplemental oxygen requirement.
Results: Children admitted with pH1N1 were older than
seasonal inﬂuenza A admissions (hospital admission:
6.5 vs 3.3 years, p<0.01; ICU admission: 7.3 vs
3.6 years, p¼0.02). Children hospitalised with pH1N1
were more likely to have a pre-existing diagnosis of
asthma (15% vs 5%, p<0.01); however, there was no
difference in the severity of pre-existing asthma between
the two groups. After controlling for obesity, asthma
(OR 4.59, 95% CI 1.42 to 14.81) and age $5y e a r s( O R
2.87, 95% CI 1.60 to 5.16) were more common risk
factors in admitted children with pH1N1. Asthma was
a signiﬁcant predictor of the need for intensive care in
patients with pH1N1 (OR 4.56, 95% CI 1.16 to 17.89)
but not in patients with seasonal inﬂuenza A.
Conclusion: While most pH1N1 cases presented with
classic inﬂuenza-like symptoms, risk factors for severe
pH1N1 disease differed from seasonal inﬂuenza A.
Older age and asthma were associated with increased
admission to hospital and ICU for children with pH1N1.
INTRODUCTION
In a large global pooled analysis of patients of
all ages, the risk factors for severe pandemic
H1N1 (pH1N1) disease have been found to
have some notable differences from seasonal
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- Young age and underlying medical conditions
have traditionally been considered risk factors for
severe inﬂuenza in children.
- Children admitted with pH1N1 inﬂuenza are more
likely to have asthma; however, the impact of
asthma severity is unknown.
Key messages
- The presence of asthma and increased age, but
not severity of asthma, were more common risk
factors for hospitalisation with severe H1N1
inﬂuenza than with seasonal inﬂuenza A.
- These results suggest that in future pandemics,
certain high-risk groups may be more adversely
affected than expected with seasonal inﬂuenza.
- Treatment of pH1N1 inﬂuenza with oseltamivir
did not appear to be associated with differing
outcomes or severity of disease.
Strengths and limitations of this study
- The strength of this study is that it compares
a large number of children admitted with
microbiologically conﬁrmed pH1N1 to those
admitted over 5 years with seasonal inﬂuenza
A. For each admitted child with suspected
asthma, at least two physicians reviewed the
case to conﬁrm a diagnosis of pre-existing
asthma and to grade the asthma as mild,
moderate or severe.
- The main limitations of this study include its
retrospective design, single-centre site, the
inability to calculate population-based rates and
that the number of admitted patients with
asthma, particularly to ICU, was small.
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Open Access Researchinﬂuenza, including younger age, obesity and preg-
nancy.
1 In the paediatric population, infants and young
children have traditionally been considered at risk for
severe seasonal inﬂuenza.
23However, recently published
paediatric studies suggest that while most cases of
pH1N1 are relatively mild, older children, especially
those suffering from asthma and obesity, may be at
higher risk for severe disease. Rates of paediatric inten-
sive care admission, mechanical ventilation, and
mortality associated with pH1N1 may be higher than
those associated with seasonal inﬂuenza.
4e7
A previous study from our centre following the ﬁrst
wave of the pandemic found that children admitted with
pH1N1 were signiﬁcantly older and more likely to have
asthma than those admitted with seasonal inﬂuenza A.
8
In late 2009, a second wave of pH1N1 resulted in more
admissions to our hospital. The increase in pH1N1 cases
allowed us to verify the ﬁndings of our initial study and
identify independent risk factors for admission to the
intensive care unit (ICU) among pH1N1 and seasonal
inﬂuenza hospitalised cases through multivariable anal-
yses. Finally, we wanted to understand how differences in
diagnostic methods and treatment between pH1N1 and
seasonal inﬂuenza might affect outcomes. Thus, our
primary goals in this study were to compare the age-
adjusted proportions of children with asthma admitted
to hospital and the ICU with pH1N1 relative to those
admitted with seasonal inﬂuenza and to determine
whether age and asthma are independent predictors of
ICU admission in pH1N1 as well as seasonal inﬂuenza
infection. Secondary goals were to describe clinical
features, other markers of illness severity and effect of
antiviral therapy and diagnostic methods on outcomes in
children with pH1N1.
DESIGN
We identiﬁed and reviewed health records of all labora-
tory-conﬁrmed cases of pH1N1 in children younger than
18 years admitted in 2009 to The Hospital for Sick Chil-
dren (SickKids), a large paediatric referral hospital in
Toronto, Canada, with over 14000 admissions per year.
9
Cases were identiﬁed through a review of microbiology
laboratory records. We compared children admitted with
pH1N1 to those admitted with seasonal inﬂuenza A
during the 2004e2005 through 2008e2009 inﬂuenza
seasons. In order to exclude potential hospital-acquired
infections, we excluded any children who developed
inﬂuenza-like symptoms on or after the third day of
admission. Testing was done at the clinical discretion of
the attending physician. All patients with inﬂuenza-like
illness were initially screened for inﬂuenza by direct
immunoﬂuorescence assay (DFA). During the ﬁrst wave of
the pandemic, all inpatient respiratory samples were tested
using reverse transcription PCR with primers developed by
the National Microbiology Laboratory, Winnipeg, Mani-
toba, Canada.
10 During the second wave, all inpatient
respiratory samples were tested with a commercial real-
time reverse transcription PCR kit (RTPCR Kit 1.0; Astra
Diagnostics, Hamburg, Germany). Seasonal inﬂuenza
cases were identiﬁed through DFA and/or viral culture.
Two physicians (MS and DT) reviewed each potential case
of asthma to conﬁrm the diagnosis and determine severity
(web table). Any discrepancies were adjudicated by an
asthma specialist (PS).
Comparisons were made between the pH1N1 and
seasonal inﬂuenza A groups and between the ﬁrst and
second waves of pH1N1. Differences in normally
distributed continuous variables were analysed using
Student’s t test. Comparisons of skewed data (length of
stay and age) were analysed using non-parametric
ManneWhitney and KruskaleWallis methods. The c
2 or
Fisher’s exact test was used to compare categorical vari-
ables between groups and as a test of heterogeneity
among multiple proportions. We performed multivari-
able logistic regression to (1) adjust for the potential
confounding effect of age (as a continuous variable and
categorical variable) on asthma as a risk factor in
comparing the severity of pH1N1 and seasonal inﬂuenza
A and (2) construct models of risk for ICU admission in
pH1N1 and seasonal inﬂuenza A infection that included
age (as a continuous variable and categorical variable),
asthma and obesity as independent variables. All statis-
tical analysis was performed using Stata SE V.10.
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RESULTS
One hundred and seventy-nine children with pH1N1
were admitted in 2009 in two waves (May to July 2009
n¼58, September to December 2009 n¼118) (ﬁgure 1),
of whom three were excluded because the onset of
symptoms was more than 3 days after admission, leaving
a total of 176 cases included for analysis. Two hundred
children were admitted to hospital with seasonal inﬂu-
enza A over ﬁve seasons (2004e2005, n¼46; 2005e2006,
n¼26; 2006e2007, n¼36; 2007e2008, n¼56;
2008e2009, n¼36). There were no differences across the
years of seasonal inﬂuenza cases in terms of demo-
graphic characteristics, underlying risk factors or
outcomes (data not shown).
Demographic characteristics
Characteristics of children with pH1N1 and seasonal
inﬂuenza are shown in table 1. Children with pH1N1
were signiﬁcantly older than those with seasonal inﬂu-
enza A (6.5 vs 3.3 years, p<0.01). The proportion of
children 5 years and older was higher in pH1N1 (61% vs
36%, p<0.01), whereas the proportion under 2 years was
higher in seasonal inﬂuenza A (37% vs 18%, p<0.01).
Children admitted to ICU with pH1N1 were older than
those with seasonal inﬂuenza A (7.3 vs 3.6 years, p¼0.02).
Disease severity
Requirement and duration of oxygen therapy, ICU
admission, mechanical ventilation and total length of
hospital stay are shown in table 1. Fifty-nine (34%)
patients admitted with pH1N1 required oxygen supple-
mentation. Thirty-two (18%) children with pH1N1
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Age and asthma as risk factors for severe H1N1 inﬂuenzarequired admission to ICU and of these, 18 (56%)
required mechanical ventilation. There was no differ-
ence in ICU admission or need for mechanical ventila-
tion between pH1N1 and seasonal inﬂuenza A. More
children admitted during the ﬁrst wave required oxygen
than those admitted during the second wave (47% vs
28%, p¼0.01). When examining only children who did
not receive antiviral therapy, the difference in oxygen
use between waves 1 and 2 remained signiﬁcant (48% vs
19%, p¼0.03). None of the patients with pH1N1 died.
Clinical and laboratory characteristics
Most pH1N1 cases presented with fever and cough. More
than one-third had gastrointestinal symptoms (table 2).
The laboratory results of children admitted with pH1N1
are shown in table 3. Four patients had positive blood
cultures during their admission (Streptococcus pneumoniae
(two patients), Viridans group Streptococcus (one
patient), Pseudomonas aeruginosa (one patient)).
Risk factors
Children with pH1N1 compared to those with seasonal
inﬂuenza A were more likely to have a history of asthma
(15% vs 5%, p<0.01); however, there was no difference
in the severity of asthma between the two groups (table
4). Cardiac disease (11% vs 4%, p¼0.02) and age under
2 years with no other risk factors (18% vs 9%, p¼0.02)
were more common in children hospitalised with
seasonal inﬂuenza A. In patients requiring intensive
care, history of asthma was more common in pH1N1
than in seasonal inﬂuenza A; however, this difference did
not reach statistical signiﬁcance (19% vs 3%, p¼0.10). In
a multivariable analysis including obesity, age category
and asthma, both age $5 (with age <2 as reference)
(OR 2.87, 95% CI 1.60 to 5.16) and history of asthma
(OR 4.59, 95% CI 1.42 to 14.81) were more common as
risk factors in admitted children with pH1N1 compared
to seasonal inﬂuenza A. In the same analysis but using
age as a continuous rather than categorical variable,
asthma remained more common as a risk factor in
pH1N1 (OR 8.77, 95% CI 1.85 to 41.52). Table 5 displays
multivariable logistic regression analyses for predictors
of ICU admission with pH1N1 and with seasonal inﬂu-
enza A infection. In multivariable models including
obesity, age category and underlying asthma as inde-
pendent variables, asthma was a signiﬁcant predictor of
the need for intensive care with pH1N1 infection (OR
4.56, 95% CI 1.16 to 17.89) but not with seasonal inﬂu-
enza A infection. When the multivariable models
included age as a continuous instead of categorical
variable, underlying asthma remained a signiﬁcant
predictor of the need for ICU care with pH1N1 infection
(OR 5.22, 95% CI 1.23 to 22.08). In children with
asthma, 29% of those with pH1N1 versus 33% of those
with seasonal inﬂuenza A presented with acute wheeze
(p¼0.81). In children without underlying asthma, there
was no difference in presentation with acute wheeze in
those with pH1N1 (15%) and those with seasonal
inﬂuenza A (12%) (p¼0.51).
Diagnosis and management
At our institution, seasonal inﬂuenza was diagnosed by
DFA supplemented with viral culture, whereas cases
positive by DFA for pH1N1 required conﬁrmation by
Figure 1 Number of pH1N1 detected, SickKids, by report week, 2009e2010.
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nostic methods, we re-analysed all cases restricting solely
to those positive by DFA. The only changes from the
previously presented results were that the length of stay
in hospital was longer in seasonal inﬂuenza A (median
3.5 vs 3 days, p¼0.03) and that underlying chronic lung
disease (excluding asthma) was no longer signiﬁcantly
more common in those admitted to ICU with seasonal
inﬂuenza A (p¼0.09).
Children with pH1N1 were more likely to receive
antiviral therapy (61% vs 8%, p<0.01). There were
signiﬁcant changes in how pH1N1 was managed between
waves; 19% of children received antiviral therapy during
wave 1 compared to 82% in wave 2 (p<0.01). However,
when comparing all children with pH1N1 who received
antiviral therapy to those who did not, there were no
signiﬁcant differences in the need for ICU admission
(22% vs 14%, p¼0.07), mechanical ventilation (14% vs
8%, p¼0.08) or length of stay in hospital (median dura-
tion 3 vs 3 days, p¼0.68). To test if sicker children
received antiviral therapy, we compared all available
Canadian Triage and Acuity Scores,
13 a standardised
Table 2 Clinical characteristics of pH1N1 and seasonal inﬂuenza by age category























Fever 31 (100) 36 (97) 99 (92) 166 (94) 64 (86) 45 (83) 59 (82) 168 (84)
Cough 29 (94) 34 (92) 84 (78) 147 (84) 34 (46) 29 (54) 39 (54) 102 (51)
Gastrointestinal 14 (45) 16 (43) 40 (37) 70 (40) 13 (15) 14 (26) 6 (8) 33 (16)
Wheeze 4 (13) 8 (22) 24 (22) 36 (20) 11 (15) 5 (9) 14 (19) 30 (15)
Pneumonia 11 (35) 12 (32) 29 (27) 52 (30) 9 (12) 8 (15) 19 (26) 36 (18)
Apnoea 3 (10) 3 (8) 2 (2) 8 (5) 0 (0) 0 (0) 0 (0) 0 (0)
Seizure 2 (7) 5 (14) 2 (2) 9 (5) 8 (11) 6 (11) 4 (6) 18 (9)
Encephalopathy 1 (3) 1 (3) 2 (2) 4 (2) 0 (0) 0 (0) 1 (14) 1 (0.5)
Myocarditis 0 (0) 1 (3) 1 (1) 2 (1) 0 (0) 0 (0) 0 (0) 0 (0)
Myositis 0 (0) 0 (0) 2 (2) 2 (1) 0 (0) 1 (2) 0 (0) 1 (0.5)
pH1N1, pandemic H1N1.
Table 1 Demographic and clinical characteristics of pH1N1 and seasonal inﬂuenza
Characteristic









Sex, male, n (%) 35 (60) 72 (61) 0.93 107 (61) 108 (54) 0.18
Age, years, median (IQR) 6.4 (3.4e10.1) 6.5 (2.9e11.4) 0.81 6.5 (3.0e10.6) 3.3 (1.4e7.8) <0.01
Age group, years, n (%)
<2 8 (14) 23 (19) 0.35 31 (18) 74 (37) <0.01
2t o<5 13 (22) 24 (20) 0.75 37 (21) 54 (27) 0.18
$5 37 (64) 71 (60) 0.64 108 (61) 72 (36) <0.01
Admitted to ICU
No. (%) of children 12 (21) 20 (17) 0.36 32 (18) 31 (15) 0.49
Age, years, median (IQR) 5.8 (3.2e7.3) 9.2 (5.4e11.4) 0.13 7.3 (4.0e10.6) 3.6 (1.5e9.7) 0.02
Required mechanical ventilation
No. (%) of children 7 (12) 11 (9) 0.57 18 (10) 19 (10) 0.81
No. (%) of children
admitted to ICU
7 (58) 11 (55) 0.85 18 (56) 19 (61) 0.69
Required supplemental oxygen
No. (%) of children 26 (47) 33 (28) 0.01 59 (34) NA NA
Duration of oxygen, days,
median (IQR)
4( 2 e6) 3 (2e7) 0.73 3 (2e6) NA NA
Length of stay, days, median (IQR)
In hospital 4 (2e6) 3 (2e5) 0.06 3 (2e5) 4 (2e7) 0.12
In ICU 3.5 (2.5e17) 2 (1.5e5) 0.08 3 (2e8) 2 (1e5) 0.24
Antiviral therapy, n (%) 11 (19) 97 (82) <0.01 108 (61) 16 (8) <0.01
Bold values are signiﬁcantly different as deﬁned by a p value <0.05.
ICU, intensive care unit; pH1N1, pandemic H1N1.
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who did (n¼65) and did not (n¼42) receive antiviral
therapy and did not ﬁnd a signiﬁcant difference between
the two groups (p¼0.70).
DISCUSSION
Most cases of pH1N1 presented with a classic inﬂuenza-
like illness, with no convincing evidence that pH1N1 was
more severe than seasonal inﬂuenza. However, the risk
factors for admission to hospital and ICU differed
between pH1N1 and seasonal inﬂuenza. Older age was
a greater risk factor for admission to hospital and ICU
for pH1N1, and asthma was a greater risk factor for
hospitalisation for pH1N1. These results corroborate
earlier research based on fewer cases from our institu-
tion
8 as well as a recent study from Colorado comparing
children admitted to hospital with pH1N1 to those with
2008e2009 seasonal inﬂuenza A or B.
14 Conversely,
underlying cardiac disease in those admitted to hospital
and non-asthma chronic lung disease in those admitted
to ICU were signiﬁcantly more common in seasonal
inﬂuenza A. These results suggest that risk factors for
new inﬂuenza strains and that high-risk groups during
future pandemics may not be simply extrapolated from
the experience with seasonal strains. Guidelines from
the Public Health Agency of Canada highlighted chil-
dren <2 years of age as a high-risk group for pH1N1.
15
However, our results of a median age of 6.5 years in
hospitalised patients with pH1N1 are remarkably similar
to studies from California
16 (median age 6 years) and
Japan
17 (median age 7 years). While we found the
proportion of hospitalised cases higher in older age
categories in pH1N1, in the absence of community
population-based epidemiological data, we are not able
to comment on any differences that may exist in age-
speciﬁc attack, hospitalisation or ICU admission rates in
our study population.
This study was not designed to identify the impact of
differing management strategies on severity and
outcomes of pH1N1. However, in contrast to the ﬁrst
study from our centre, in this study, differences in anti-
viral use between waves allowed for an interesting
natural experiment. Overall, during the ﬁrst wave, 0%,
46% and 14% of children aged younger than 2 years,
2e4 years and 5 years and older, respectively, received
oseltamivir. During the second wave, 65%, 88% and 86%
Table 3 Haematologic laboratory values for children




























112 (66) 102 (53)
For pH1N1 inﬂuenza, 174 children had complete blood count and
170 had differential performed. For seasonal inﬂuenza, 196
children had complete blood count and 193 had differential
performed.
pH1N1, pandemic H1N1.
Table 4 Risk factors for admission to hospital and intensive care unit, pH1N1 versus seasonal inﬂuenza A*
Risk factor









Asthma 26 (15)z 9 (5) <0.01 6 (19) 1 (3) 0.10
Mild asthma 16 (62) 7 (78) 0.38 4 (67) 1 (100) 1.00
Moderate asthma 6 (23) 1 (11) 0.44 1 (17) 0 (0) 1.00
Severe asthma 4 (15) 1 (11) 0.75 1 (17) 0 (0) 1.00
Chronic lung disease 12 (7) 13 (7) 0.92 0 (0) 5 (16) 0.02
Obesityx 8 (7) 14 (9) 0.64 3 (20) 2 (9) 0.38
Cardiac disease 7 (4) 21 (11) 0.02 3 (9) 4 (12) 0.71
Haemoglobinopathy 19 (11) 22 (11) 0.95 1 (3) 1 (3) 0.75
Immunodeﬁciency 32 (18) 42 (21) 0.49 1 (3) 2 (3) 0.61
Neurological impairment 21 (12) 26 (13) 0.76 6 (19) 8 (26) 0.56
Age <2 years and no
other risk factors
16 (9) 35 (18) 0.02 2 (6) 4 (13) 0.43
Bold values are signiﬁcantly different as deﬁned by a p value <0.05.
*Any differences between the numbers presented in table 4 and those from O’Riordan et al
8 are the result of a re-assessment of all pH1N1 and
seasonal inﬂuenza A cases for this study.
yFisher’s exact test used when cell size is small.
zPercentages in parentheses.
xObesity was deﬁned according to guidelines from the Centers for Disease Control as a body mass index $95th percentile for age in children
2 years and older.
12 Obesity could not be calculated for 45 (31%) and 68 (54%) children $2 years in the seasonal and pH1N1 groups,
respectively.
pH1N1, pandemic H1N1.
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5 years and older, respectively, received antiviral therapy.
While there was no difference in markers of disease
severity, including ICU admission, mechanical ventila-
tion and length of hospital stay between the two
pandemic waves, there was a greater need for oxygen in
children hospitalised during wave 1. This difference only
remained signiﬁcant when restricting the analysis to
those who did not receive antiviral therapy. This ﬁnding
may reﬂect increased antiviral use directed at sicker
children during wave 2, while the mildest cases did not
receive antivirals.
In the previous analysis of the ﬁrst wave of pH1N1 in
Toronto, asthma was a more signiﬁcant risk factor for
pH1N1 than for seasonal inﬂuenza.
8 In this study, with
more than three times the number of pH1N1 cases, we
conﬁrm the signiﬁcance of asthma as a major risk factor;
controlling for obesity and age (as a continuous variable),
asthma was more likely to be present in hospitalised
children with pH1N1 (OR 4.59, 95% CI 1.42 to 14.81)
than those with seasonal inﬂuenza A. In pH1N1 cases,
asthma was associated with admission to ICU (OR 4.56,
95% CI 1.16 to 17.89). This is in contrast to seasonal
inﬂuenza A in which underlying asthma was not signiﬁ-
cantly associated with ICU admission (OR 2.47, 95% CI
0.24 to 25.80). We did not ﬁnd that the severity of asthma
was differentially associated with hospitalisation or ICU
admission between pH1N1 and seasonal inﬂuenza A.
While six (19%) ICU admissions with pH1N1 had asthma
(four mild, one moderate and one severe) compared to
only one (3%) (mild) ICU admission with seasonal
inﬂuenza, the numbers were too small to be able to
demonstrate a difference. In a large California study of
345 children hospitalised or who died of pH1N1, 31% of
hospitalised children and 34% of ICU and/or fatal cases
had asthma.
16 In Japan, 14% of non-severe cases of
pH1N1 and 47% of severe cases had asthma,
17 while a UK
study found that asthma was present in 16% of children
<16 years and 31% of adults.
18 None of these studies
examined severity of asthma or the differences between
pH1N1 and seasonal inﬂuenza.
Immunological studies of severe pH1N1 cases have
shown delayed expression of genes involved in the
adaptive immune response, delayed viral clearance and
increased levels of innate immunity mediators involved
in the Th1 and Th17 response.
19 20 Children with
underlying asthma and other groups (such as pregnant
women) thought to be at higher risk for severe pH1N1
disease
21e23 may have an altered immunological and
inﬂammatory response to this virus resulting in
increased disease severity. Interleukin 5 has been shown
to be highly expressed in bronchial mucosa of patients
with asthma,
24 is a key player in eosinophilic inﬂamma-
tion
25 and has been found to be higher in serum of
patients with pH1N1 with pneumonia than those
without.
26 However, further research is needed to fully
understand this association. While there is some
evidence in adults that adjuvant corticosteroids in severe
pH1N1 may increase mortality,
27 the impact of inhaled
corticosteroids in childhood asthma on pH1N1 severity
is not known and this study was not designed nor
powered to address this question.
Inﬂuenza vaccination coverage in children with
asthma has been poor in many countries.
28 29 Some
physicians remain sceptical of the need for vaccinating
all children with asthma,
30 while others tend to prioritise
children with more severe asthma.
31 Deﬁnitive data have
been elusive.
32 Our ﬁndings suggest that physicians
should ensure all children with asthma under their care
have been vaccinated against pH1N1 (which is currently
included in the standard seasonal inﬂuenza vaccine),
regardless of severity of asthma, at least until randomised
controlled trial data become available.
There are several limitations in this study including its
retrospective design, single-centre site and inability to
calculate population-based rates. The number of
admitted patients with asthma, particularly to ICU, was
small, and this may have hindered our ability to identify
differences in risk based on severity. Additionally, we
identiﬁed only the single most important underlying
risk factor (with the exception of asthma, obesity and
age, which were all collected for each patient), and thus,
Table 5 Multivariable regression of asthma, obesity and age category as risk factors for intensive care unit admission with
pH1N1 and seasonal inﬂuenza A
Risk factor
pH1N1 Seasonal inﬂuenza
OR Lower 95% CI Upper 95% CI OR Lower 95% CI Upper 95% CI
Asthma* 4.56 1.16 17.89 2.47 0.24 25.80
Obesity 4.18 0.76 22.95 1.06 0.20 5.64
Age 0 to <2 years 1.00 1.00
Age 2 to <5 years 1.70 0.30 9.48 1.40 0.44 4.44
Age $5 years 0.89 0.19 4.07 0.62 0.19 1.98
Bold values are signiﬁcantly different as deﬁned by a p value <0.05.
*Asthma was also more common as a risk factor (OR 5.22, 95% CI 1.23 to 22.08) for admission to ICU in pH1N1 compared to seasonal
inﬂuenza A (with age as continuous variable).
Unadjusted (univariate) ORs for pH1N1: asthma (OR 1.43, 95% CI 0.52 to 3.91), obesity (OR 3.25, 95% CI 0.81 to 19.69), age 0 to <2 years
(OR 1.00), age 2 to <5 years (OR 2.18, 95% CI 0.51 to 9.26), age $5 years (OR 2.39, 95% CI 0.66 to 8.58). Unadjusted (univariate) ORs for
seasonal inﬂuenza A: asthma (OR 0.67, 95% CI 0.08 to 5.56), obesity (OR 1.14, 95% CI 0.22 to 5.99), age 0 to <2 years (OR 1.00), age 2 to
<5 years (OR 1.30, 95% CI 0.51 to 3.32), age $5 years (OR 0.92, 95% CI 0.36 to 2.33).
pH1N1, pandemic H1N1.
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Age and asthma as risk factors for severe H1N1 inﬂuenzawe were unable to explore interactions between risk
factors in patients with multiple comorbidities. Our
metrics of inﬂuenza severitydICU admission and
duration of staydmay be impacted by non-medical
factors, such as bed availability. In regard to oxygen use,
we did not have data on oximetry or criteria that were
used by physicians to start or stop oxygen supplemen-
tation, and thus, it was difﬁcult to determine the
signiﬁcance of the difference seen in wave 1 versus wave
2. In regard to oseltamivir use, we did not extract data
on dosage, duration or when the medication was begun.
However, the use of oseltamivir in this study was at the
discretion of the attending physician and thus reﬂective
of ‘real life’ use. It is possible that we did not identify all
patients at our hospital with inﬂuenza (seasonal or
pH1N1) due to false-negative testing or testing being
performed at an outside hospital and not repeated at
our institution; however, we expect both these cases to
be very rare.
CONCLUSIONS
Risk factors for severe disease, speciﬁcally the presence
of underlying asthma and increased age, differed
between pH1N1 and seasonal inﬂuenza in children.
There was no difference in overall disease severity. These
results suggest that in future pandemics with new inﬂu-
enza strains, high-risk groups may be different than
those traditionally considered as such. The reasons for
the differing inﬂuence of asthma and age on host
response to pH1N1 are not understood, and further
study of the underlying mechanisms contributing to
these differences may shed new light on the
hostepathogen immunobiology of a pandemic strain of
inﬂuenza virus. This study emphasises the need to
ensure that all children with asthma have been vacci-
nated against pH1N1 inﬂuenza, regardless of the severity
of their asthma.
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